Verition Fund Management
NUVB icon

Verition Fund Management’s Nuvation Bio NUVB Stock Holding History

Verition Fund Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-125,216
Closed -$1.12M – 3154
2025
Q4 		$1.12M Buy
+125,216
New +$776K ﹤0.01% 2063
2025
Q2 		– Sell
-151,575
Closed -$267K – 3783
2025
Q1 		$267K Sell
151,575
-62,580
-29% -$142K ﹤0.01% 2916
2024
Q4 		$570K Buy
214,155
+200,780
+1,501% +$517K ﹤0.01% 2402
2024
Q3 		$30.6K Sell
13,375
-13,409
-50% -$40.9K ﹤0.01% 3061
2024
Q2 		$78.2K Buy
+26,784
New +$81.7K ﹤0.01% 2758
2023
Q4 		– Sell
-12,896
Closed -$17.3K – 2578
2023
Q3 		$17.3K Buy
+12,896
New +$21.5K ﹤0.01% 2228

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Verition Fund Management's NUVB Position: Q1 2026 in Review

Verition Fund Management sold out of Nuvation Bio (NUVB) in Q1 2026, closing a stake of 125,216 shares — an estimated $1.12M sold.

Verition Fund Management first reported a position in NUVB in Q3 2023 and held it in 6 quarters. The position peaked at $1.12M in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Verition Fund Management reported no remaining Nuvation Bio position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 125,216 Nuvation Bio shares in Q1 2026, an estimated $1.12M.
  • Verition Fund Management first reported a position in Nuvation Bio in Q3 2023 and held it in 6 quarters.
  • Verition Fund Management's Nuvation Bio position peaked at $1.12M in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.